DDIT3 and mature T-cell and NK-cell non-Hodgkin lymphoma: For example, romidepsin plus CHOP is being investigated in a single-arm, phase Ib/II trial of patients with newly diagnosed PTCL (NCT01280526 and NCT01796002), including 37 patients with previously untreated PTCL [70].